Atyr_Logo.png
aTyr Pharma Announces LTBP1 as Target of DARS tRNA Synthetase Fragment
December 15, 2022 08:00 ET | aTyr Pharma, Inc.
LTBP1 is key regulator of TGF-β, a major driver of fibrosis. Latest target identified from company’s platform in collaboration with Dualsystems Biotech AG. SAN DIEGO, Dec. 15, 2022 (GLOBE...
Atyr_Logo.png
aTyr Pharma to Present at the Jefferies London Healthcare Conference
October 25, 2022 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, Oct. 25, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
Atyr_Logo.png
aTyr Pharma Announces Research Collaboration with Dualsystems Biotech AG to Identify 10 New Therapeutic Targets
October 11, 2022 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or “the Company”), a biotherapeutics company engaged in the discovery and development of first-in-class medicines...
Atyr_Logo.png
aTyr Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
September 06, 2022 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO , Sept. 06, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
Atyr_Logo.png
aTyr Pharma to Present Poster at the European Respiratory Society (ERS) International Congress 2022
September 01, 2022 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
Atyr_Logo.png
aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2022 Financial Results
August 04, 2022 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
Atyr_Logo.png
aTyr Pharma Announces New tRNA Synthetase Discovery Programs
February 11, 2021 08:00 ET | aTyr Pharma, Inc.
Advancement of selected AARS and DARS fragments primarily targeting cancer Programs will accelerate discoveries initially focusing on natural killer (NK) cell biology SAN DIEGO , Feb. 11, 2021 ...
aTyr Pharma Logo New.jpg
aTyr Pharma to Present at Jefferies 2018 Global Healthcare Conference
May 31, 2018 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
Atyr_Logo.png
aTyr Pharma to Host Conference Call and Webcast of Full Year 2017 Financial Results on March 19, 2018
March 07, 2018 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
Atyr_Logo.png
aTyr Pharma to Present at Two Upcoming Investor Conferences in March
March 01, 2018 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...